Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

000766
stockHealthcarePharmaceuticals
$6/day into 000766 since 2015 would be worth $47,049 today — 2.8× the money.
Try your own number →

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of 000766-SZ would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (1997) — listing
$183,798
4.2×
$264,419
4.2×
Year 6 (2002)
$162,960
4.5×
$235,157
4.5×
Year 11 (2007)
$94,413
3.3×
$138,895
3.3×
Year 16 (2012)
$65,394
3.1×
$96,474
3.1×
Year 21 (2017)
$41,042
3.0×
$60,362
3.0×
Year 26 (2022)
$16,030
2.5×
$23,515
2.5×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with 000766

For illustration only — not investment advice. Past performance is not indicative of future results.